A humanized anti-integrin monoclonal antibody is Vedolizumab. It functions by blocking the immune component called integrin in the intestines. Thus, it is given as an injection to treat autoimmune and other inflammatory conditions of the gut like Crohn's disease or inflammatory bowel disease.
Vedolizumab - Uses, Effects, Conventional Medicines
Vedolizumab is a monoclonal antibody drug approved to treat ulcerative colitis and Crohn’s disease. The article below is detailed on Vedolizumab.
